SS Innovations Enters Licensing Agreement with Johns Hopkins University

13 October 2023 | Friday | News

Company’s flagship SSi Mantra surgical robotic system now installed at the university’s Baltimore campus

SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announces it has entered into an agreement with Johns Hopkins University and has installed its SSi Mantra surgical robotic system at the university’s campus in Baltimore, MD.

Under the terms of the agreement, SS Innovations has installed one system at the Johns Hopkins Minimally Invasive Surgical Training and Innovation Center (MISTIC), where the next generation of surgeons and health care providers are trained in the use of the latest technological and procedural medical advancements. SS Innovations and the MISTIC team will share the benefits of these combined research activities.

Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, said, “We are pleased and proud to announce that SS Innovations’ flagship surgical robotic device, the first device of its kind to be made in India, has been installed at the Johns Hopkins University in Baltimore, MD.

“This agreement marks the beginning of a co-development partnership pact to advance to broader procedural applications of medical robotics. Robotic surgery offers clear benefits to hospitals, surgeons and patients, with its improved accuracy and reduced risk of pain and infection. Our mission is to use our SSi Mantra to bring this gold-standard of medical care to the vast populations throughout the world who currently lack access to this type of precision surgery.

“The SSi Mantra is one of the only systems in the world to be distinctly cost-effective with broad-spectrum surgical applications, including cardiovascular, thoracic, and head and neck surgery. It has been granted regulatory approval in India, the United Arab Emirates and Guatemala and is clinically validated in more than 40 different types of surgical procedures. We are currently working to secure regulatory approvals in the United States and Europe in 2024 and 2025.”

SS Innovations’ SSi Mantra surgical robotic system will be managed onsite at the Johns Hopkins Hospital and will be operated by the university’s lab teams. The two organizations will also launch a knowledge forum showcasing demonstrations and discussions for the benefit of the global medical robotics community.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close